- Details
- (Length of Discussion: 12 min) Alicia Morgans and Josh Meeks highlight ongoing trials in non-muscle invasive bladder cancer. Reviews of SWOG 1602 and 1605, highlight the great work being done in the search for treatment options for patients with this disease, the ultimate hope for patients is to retain their bladder and potentially be cancer-free. Biographies: Joshua J Meeks, MD, Ph.D., is an Assi...
|
- Details
- (Length of Discussion: 22 min) Alicia Morgans has a discussion with Dan George uncovering details about the IRONMAN Registry. The objective is to look globally at advanced prostate cancer, both with the metastatic and the castrate-resistant populations, seeking to understand patient outcomes and their experiences through this process. Biographies: Daniel George, MD Alicia Morgans, MD, MPH Read the...
|
- Details
- (Length of Interview: 19 min) A detailed interview with Jeannette Potts by Diane Newman on the evolution in the treatment of patients with prostatitis. The clinical treatment changes, as well as the philosophy in diagnosis, play a great role in her strategies for each patient she encounters. Biographies: Jeannette M. Potts, M.D Men’s Health GU Specialist, Co-founder Vista Urology & Pelvic Pain Par...
|
- Details
- (Length of Discussion: 20 min) Alicia Morgans and David Penson discuss the relevance of Prostate Cancer Awareness Month and the importance of elevating the awareness for men and their respective caregivers about prostate cancer and other men's health issues and the need to be screened routinely for prostate cancer. Biographies: David F. Penson, MD, MPH, is the Paul V. Hamilton, M.D. and Virginia E...
|
- Details
- (Length of Presentation: 10 min) Christopher Wallis presents the findings of a retrospective cohort study of all women in Ontario undergoing surgical management of stress incontinence between 1994 and 2016. Utilizing a time-series analysis, they were able to characterize the trends in utilization of a variety of procedures over time. He relates trend findings to that of regulatory health warnings...
|
- Details
- Alicia Morgans and Matt Cooperberg discuss the controversial topic of how to optimally screen for prostate cancer based on the final recommendations from the U.S. Preventive Services Task Force. Biographies: Matthew Cooperberg, MD, MPH, FACS, UCSF Helen Diller Family Comprehensive Cancer Center Alicia Morgans, MD, MPH Further Related Content: Biomarker Debate: Adopt, Expand, Trust (PRO) HPFS Healt...
|
- Details
- Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Biographies: Daniel Spratt, MD, Tenured Full Professor of Radiation Oncology and a leader in Prostate and Spine malignancies. Chief of the Genitourinary Radiotherapy Program, Associate Chair of Clinical Research, and the Laurie Snow Endowed Research Professor i...
|
- Details
- (Length of Discussion: 6 min) Charles Ryan and Dan George reflect on the dramatic changes clinicians have seen over the last 12 years in treating kidney cancer. Dan reviews the highlights of the CARMENA trial and the impact that the results have made to treatment strategies for patients, stressing the value of collaborative care and patient selection. Biographies: Daniel George, MD Charles J. Ryan...
|
- Details
- (Length of Demonstration: 3 min) Demonstration: En-bloc TURBT (E-TUBT) with Collins Loop: A New Endoscopic Treatment in the Bladder Tumour R. Giulianelli, L. Albanesi, B.C. Gentile, , G. Mirabile, G. Rizzo, P. Tariciotti, G. Vincenti Center of High Specialization and Training of Lower Urinary Tract, Nuova Villa Claudia, Rome, Italy
|
- Details
- (Length of Discussion: 21 min) Petros Grivas and Pedro Barata discuss how a recent study they performed applies to the field of metastatic urothelial cancer regarding the use of checkpoint inhibitors in a patient population outside the context of the clinical trial and the main objectives, results, and conclusion of that study as well as implications for the field. Biographies: Pedro Barata, MD, M...
|
